Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2025-12-25 @ 3:25 AM
NCT ID:
NCT05617105
Eligibility Criteria:
Inclusion criteria:
* Major patient (≥18 years)
* Minor patient (1 to 17 years old)
* PEComas diagnosed in France between 01/01/1990 and 15/09/2019 and reviewed by a sarcoma referral pathologist
Exclusion criteria :
* Opposition of the patient (or the holders of parental authority) to participate in the study
* Biological tissue from a patient who does not meet all the inclusion criteria
* Classic triphasic angiomyolipoma or lymphangioleiomyomatosis
* Inability to provide informed information to the subject
* Patient under court protection
* Patient under guardianship or curatorship
Sex:
ALL
Minimum Age:
1 Year
Study:
NCT05617105
Study Brief:
Protocol Section:
NCT05617105